Background. The prevalence of thyroid cancer is rising worldwide. Although thyroid cancer
has a favorable prognosis, up to 20% of patients experienced recurrent disease during the …

Background: Papillary thyroid carcinoma (PTC) generally has an indolent course and
favorable prognosis. However, an optimal treatment strategy for asymptomatic PTC is not …

Background Although recurrence and death can occur in patients with papillary thyroid
cancer (PTC) several years after being diagnosed, the necessary duration of follow-up for …

Objective Some patients with papillary thyroid carcinoma (PTC) would suffer from
locoregional recurrences or distant metastases. This study was aimed to elucidate the …

Objective: To evaluate the risk factors influencing the recurrence of papillary thyroid
carcinoma. Methods: This meta-analysis used MEDLINE (PubMed), EMBASE and CNKI …

Background: Little is known about annual hazard rates of cancer mortality and recurrence for
papillary thyroid cancer (PTC). This study investigated the time-varying pattern of cancer …

A subgroup of patients with papillary thyroid carcinoma (PTC) also has chronic thyroiditis
(CT) as an associated disease of the thyroid. To assess the prognostic value of CT in …

Objective The incidence of papillary thyroid carcinoma (PTC) has increased in recent years
and its treatment remains controversial. The objective of this study is to identify …

Introduction Papillary thyroid carcinoma (PTC) generally shows an excellent prognosis
except in cases with aggressive backgrounds or clinicopathological features. Although the …

Background Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …